---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-000677"
form_type: "8-K"
ticker: null
cik: "0001761696"
company_name: "Crown Electrokinetics Corp."
filed_at: "2023-01-04T23:59:59+00:00"
generated_at: "2026-06-20T20:24:43.570004+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Crown Electrokinetics acquires Amerigen 7, gains $67M Charter PO, eyes $30M revenue in 2023

## Summary
- Acquired Amerigen 7 (renamed Crown Fiber Optics) for $645K cash plus assumed liabilities.
- Includes a $67M purchase order from Charter Communications for fiber-optic build in Ohio.
- Guides Crown Fiber Optics to generate ~$30M revenue and ~$10M EBITDA in 2023.
- Raised $1.2M via senior secured notes (20% OID, zero interest, 3-month maturity) and 2.5M warrants at $0.322/share.
- Warrants exercisable for 5 years at $0.322; company grants registration rights.

## SEC filing metadata
- accession: 0001213900-23-000677
- form_type: 8-K
- cik: 0001761696
- company_name: Crown Electrokinetics Corp.
- filed_at: 2023-01-04T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 2.01, 2.03, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1761696/000121390023000677/0001213900-23-000677-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1761696/000121390023000677/ea171181-8k_crownelectro.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-000677
- JSON: https://secwatch.observer/filing/0001213900-23-000677.json
- Plain text: https://secwatch.observer/filing/0001213900-23-000677.txt

## Key facts
- Debt Financings
  Crown Electrokinetics Corp. incurred senior notes of $1.2 million with certain accredited investors at do not bear interest maturing three months from the date of issuance.
  - Instrument: senior notes
  - Principal: $1.2 million
  - Counterparty: certain accredited investors
  - Rate: do not bear interest
  - Maturity: three months from the date of issuance
  - Event: incurrence
  source text: the Company sold, and the Investors purchased, $1.2 million in principal amount of senior secured notes
  evidence_url: https://www.sec.gov/Archives/edgar/data/1761696/000121390023000677/0001213900-23-000677-index.htm
- M&A Transactions
  Crown Electrokinetics Corp. completed an acquisition involving Amerigen 7 LLC for $645,000 and the assumption of certain liabilities (closed 2023-01-03).
  - Action: acquisition
  - Counterparty: Amerigen 7 LLC
  - Consideration: $645,000 and the assumption of certain liabilities
  - Closing: 2023-01-03
  source text: Amerigen sold, and the Company acquired, all of the assets of Amerigen (other than certain excluded assets set forth in the Asset Purchase Agreement) for a purchase price of (i) $645,000 and (ii) the assumption of certain liabilities of Amerigen (as set forth in the Asset Purchase Agreement). The Asset Purchase Agreement contains customary representations and
  evidence_url: https://www.sec.gov/Archives/edgar/data/1761696/000121390023000677/0001213900-23-000677-index.htm
- Material Agreements
  Crown Electrokinetics Corp. entered into Securities Purchase Agreement with certain accredited investors valued at $1.2 million (effective 2023-01-03).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain accredited investors
  - Value: $1.2 million
  - Effective: 2023-01-03
  source text: On January 3, 2023, the Company entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with certain accredited investors as purchasers (the “Investors”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1761696/000121390023000677/0001213900-23-000677-index.htm
- Material Agreements
  Crown Electrokinetics Corp. entered into Asset Purchase Agreement with Amerigen 7 LLC valued at $645,000 (effective 2023-01-03).
  - Action: entry
  - Agreement: asset purchase
  - Counterparty: Amerigen 7 LLC
  - Value: $645,000
  - Effective: 2023-01-03
  source text: The Asset Acquisition was simultaneously entered into and consummated pursuant to a certain Asset Purchase Agreement (the “Asset Purchase Agreement”) with Amerigen 7 LLC, a Texas limited liability company (“Amerigen”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1761696/000121390023000677/0001213900-23-000677-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.